Related Experiment Video
Updated: Oct 4, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Surfactant lavage and replacement in meconium aspiration syndrome with pulmonary hemorrhage
1Department of Pediatrics, Shizuoka Red Cross Hospital, Shizuoka-shi, Japan. src1@tokai.or.jp
Abstract:
We reported two case studies of meconium aspiration syndrome (MAS) with pulmonary hemorrhage in which we applied surfactant lavage and replacement. Surfactant lavage and replacement of MAS with pulmonary hemorrhage appears to be effective and safe adjunctive therapy. The relatively small replacement doses of surfactant required may be attributed to surfactant lavage followed by surfactant replacement. We suggest that surfactant lavage and replacement of MAS with pulmonary hemorrhage should be further investigated by a randomized controlled trial.
Insights
Surfactant lavage and replacement effectively treated meconium aspiration syndrome (MAS) with pulmonary hemorrhage in two cases. This adjunctive therapy shows promise for improving outcomes in neonates with severe MAS.
Area of Science:
- Neonatal Medicine
- Pediatric Pulmonology
- Critical Care
Background:
- Meconium aspiration syndrome (MAS) can lead to severe respiratory distress and pulmonary hemorrhage in newborns.
- Pulmonary hemorrhage complicates MAS, increasing morbidity and mortality.
- Current treatment strategies for MAS with pulmonary hemorrhage are limited.
Observation:
- Two neonates with MAS complicated by pulmonary hemorrhage were treated with surfactant lavage and replacement.
- The procedure involved lavage to clear meconium and hemorrhage, followed by surfactant instillation.
- Minimal replacement doses of surfactant were administered post-lavage.
Findings:
- Surfactant lavage and replacement demonstrated effectiveness as an adjunctive therapy in both cases.
- The treatment appeared safe, with no reported adverse events.
- Reduced surfactant replacement doses suggest enhanced efficacy of the lavage procedure.
Implications:
- Surfactant lavage and replacement may be a viable and safe therapeutic option for MAS with pulmonary hemorrhage.
- Further investigation through randomized controlled trials is warranted to confirm these findings.
- This approach could potentially improve respiratory support and outcomes for affected neonates.
More Related Videos
07:20Lavage-induced Surfactant Depletion in Pigs As a Model of the Acute Respiratory Distress Syndrome (ARDS)
Published on: September 7, 2016
06:22Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)
Published on: April 7, 2021
Related Concept Videos
Breathing
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Endoscopic Studies II: Thoracocentesis
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Pulmonary Cycle: Exhalation
Cardiopulmonary Resuscitation II: ACLS Airway Management
Suctioning the Nasopharyngeal Airway
Equipment Required